Fate Therapeutics (FATE) P/E (2013 - 2026)
Fate Therapeutics (FATE) P/E from Oct 1, 2013 to Jul 21, 2026. The TTM Fate Therapeutics (FATE) P/E is -2.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Fate Therapeutics (FATE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.51 | +203.32% |
| 2025 | -0.83 | -17.84% |
| 2024 | -1.01 | -52.39% |
| 2023 | -2.12 | -36.09% |
| 2022 | -3.32 | -87.33% |
| 2021 | -26.17 | -41.17% |
| 2020 | -44.48 | +215.81% |
| 2019 | -14.08 | +25.51% |
| 2018 | -11.22 | +70.24% |
| 2017 | -6.59 | +188.07% |
| 2016 | -2.29 | -21.71% |
| 2015 | -2.92 | -26.78% |
| 2014 | -3.99 | -39.02% |
| 2013 | -6.55 | N/A |
Comparison Fate Therapeutics (FATE) P/E with competitors
Fate Therapeutics (FATE) P/E is -2.51.